Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
| ▸ | HPRT1 | P00492 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | FYN | P06241 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | AHR | P35869 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | PNMT | P11086 | 4/20 | 0.39 |
| ▸ | NQO1 | P15559 | 2/20 | 0.38 |
| ▸ | CDK4 | P11802 | 1/20 | 0.36 |
| ▸ | CCND1 | P24385 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Piperazine SCHEMBL28163406 | 1.00 | KIF11 (0.46) | KIF11HPRT1ALDH1A1CYP1A2LCK | |
| Piperazine SCHEMBL27837264 | 0.98 | KIF11 (0.45) | KIF11HPRT1ALDH1A1CYP1A2LCK | |
| Piperazine SCHEMBL28190051 | 0.98 | KIF11 (0.45) | KIF11HPRT1ALDH1A1CYP1A2LCK | |
| Piperidine SCHEMBL27389317 | 0.94 | KIF11 (0.44) | KIF11HPRT1ALDH1A1CYP1A2LCK | |
| Piperazine SCHEMBL28106719 | 0.93 | KIF11 (0.41) | KIF11HPRT1ALDH1A1CYP1A2LCK | |
| SCHEMBL2089665 | 0.92 | HPRT1 (0.54) | KIF11HPRT1ALDH1A1CYP1A2LCK | |
| SCHEMBL30928215 | 0.92 | HPRT1 (0.54) | KIF11HPRT1ALDH1A1CYP1A2LCK | |
| SCHEMBL21176632 | 0.92 | HPRT1 (0.54) | KIF11HPRT1ALDH1A1CYP1A2LCK | |
| SCHEMBL27740850 | 0.92 | HPRT1 (0.54) | KIF11HPRT1ALDH1A1CYP1A2LCK | |
| SCHEMBL28077721 | 0.92 | HPRT1 (0.54) | KIF11HPRT1ALDH1A1CYP1A2LCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 252 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106083807-B | 4- amino -5- biphenyl -4- base -2- methylol -2- methvl-pentanoic acid compounds and preparation method thereof | 施万生物制药研发IP有限责任公司 | 2018-09-11 | — | — | CN | claimed |
| CN-108069959-A | A kind of nitrogen-containing hetero cyclics, its preparation method, pharmaceutical composition and application | 凯惠科技发展(上海)有限公司 | 2018-05-25 | — | — | CN | claimed |
| CN-107667108-A | NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS | 施万生物制药研发IP有限责任公司 | 2018-02-06 | — | — | CN | claimed |
| CN-107043406-A | Compound, linker-drug, and ligand-drug conjugate | 财团法人工业技术研究院 | 2017-08-15 | — | — | CN | claimed |
| CN-107029242-A | Antibody drug complex and method for producing same | 财团法人工业技术研究院 | 2017-08-11 | — | — | CN | claimed |
| CN-104662126-B9 | Liquid crystal display element, liquid crystal composition and use thereof | 捷恩智株式会社 | 2017-03-29 | — | — | CN | claimed |
| CN-104066815-B | Liquid crystal composition, application thereof and liquid crystal display assembly | 捷恩智株式会社 | 2017-03-08 | — | — | CN | claimed |
| CN-106433687-A | Liquid crystal display element, and liquid crystal composition and use thereof | 捷恩智株式会社 | 2017-02-22 | — | — | CN | claimed |
| CN-106083807-A | 4 amino 5 biphenyl 4 base 2 methylol 2 methylvaleric acid compounds and preparation method thereof | 施万生物制药研发IP有限责任公司 | 2016-11-09 | — | — | CN | claimed |
| CN-104662126-B | Liquid crystal display element, liquid crystal composition and use thereof | 捷恩智株式会社 | 2016-11-02 | — | — | CN | claimed |
| CN-102911142-A | Method for preparing 5-hydroxymethylfurfural | UNIV FUDAN | 2013-02-06 | — | — | CN | claimed |
| CN-102695706-A | Imidazopyridine derivatives as JAK inhibitors | ALMIRALL SA | 2012-09-26 | — | — | CN | claimed |
| CN-102480957-A | Methods of treating cancer and non-neoplastic conditions | PTC THERAPEUTICS INC | 2012-05-30 | — | — | CN | claimed |
| CN-102325755-A | Substituted 5,6-dihydro-6-phenyl benzo [F] isoquinoline 99.9-2-amine compound | ARQULE INC | 2012-01-18 | — | — | CN | claimed |
| CN-102212280-A | Antistatic coating composition | TOYO INK MFG CO | 2011-10-12 | — | — | CN | claimed |
| CN-101679867-A | Liquid-crystal composition and liquid-crystal display element | CHISSO CORP | 2010-03-24 | — | — | CN | claimed |
| CN-101560398-A | Tetrahydrofuran compound, liquid crystal composition and liquid crystal display device containing the liquid crystal composition | CHISSO CORP (JP) | 2009-10-21 | — | — | CN | claimed |
| CN-101228141-A | Tetrahydrobenzoxazines as stabilisers | BASF AG (DE) | 2008-07-23 | — | — | CN | claimed |
| CN-101035779-A | Tetrahydrofuran mixture, liquid crystal composition and liquid crystal display element containing liquid crystal composition | CHISSO CORP (JP) | 2007-09-12 | — | — | CN | claimed |
| CN-101003820-A | Method for producing optically active cyclopentenones and cyclopentenones produced thereby | CHIROGATE INT INC (CN) | 2007-07-25 | — | — | CN | claimed |